Mealey's Banking & Finance - New Jersey Federal Jury Awards Mylan $106 Million For Breach

NEWARK, N.J. - A nine-day trial in New Jersey federal court culminated March 25 in a $106.7 million award for Mylan Inc. and Mylan Pharmaceuticals Inc. (Mylan, collectively), on allegations that GlaxoSmithKline LLC (GSK) breached a previous settlement covering generic formulations of Paxil (Mylan Inc. and Mylan Pharmaceuticals Inc. v. SmithKlineBeecham Corp., No. 10-4809, D. N.J.).

Access this news story on lexis.com®